Management reiterated a bold target: becoming the global leader in oncology by 2030 with projected sales exceeding $50 billion annually, exceeding current consensus levels by at least threefold in ...

Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the ...

A new statewide research initiative is underway to evaluate an experimental blood test that could change the future of cancer screening.

Discover a study exploring novel drug combinations and genetic insights transforming advanced bladder cancer treatment.

A clinical trial is launching to test the effectiveness of new tests that aim to detect genetic signatures of cancer in the ...

Bladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...

Frequent cystoscopy for monitoring nonmuscle-invasive bladder cancer (NMIBC) is burdensome and costly, prompting a search for alternatives.

Bladder cancer symptoms often go unnoticed until it's too late. Learn the warning signs most people ignore and how early ...

The purpose of these estimates is to inform state and local cancer care organizations and providers, patient support programs and educators, advocates, and researchers so they can allocate resources ...

DNA profiling can help stratify risk of recurrence in patients with BCG-unresponsive NMIBC treated with atezolizumab. Read ...

The Bladder Cancer Advocacy Network (BCAN) today announced a Funding Continuity Grant initiative of up to $1 million to ...

New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with ...